Giordano Liberi

Giordano Liberi

Auto-generated profile, based on publicly available information

Giordano Liberi

Dipartimento di Genetica e di Biologia dei Microrganismi, Università degli Studi di Milano, Via Celoria 26, 20133 Milan, Italy

Research Focus & Metrics

Academic Career Length

29Years (1998-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
21 October 2004 in Nature
Verified
Journal Article
Closed access
PDF file
GIGrzegorz Ira
Grzegorz Ira
APAchille Pellicioli
Achille Pellicioli
ABAlitukiriza Balijja
Alitukiriza Balijja
XWXuan Wang
Xuan Wang
SFSimona Fiorani
Simona Fiorani
MFMarco Foiani
Marco Foiani

1 August 2001 in Nature
Verified
Journal Article
Closed access
PDF file
MLMassimo Lopes
Massimo Lopes
CCCecilia Cotta-Ramusino
Cecilia Cotta-Ramusino
APAchille Pellicioli
Achille Pellicioli
GLGiordano Liberi
Giordano Liberi
PPPaolo Plevani
Paolo Plevani
MFMarco Foiani
Marco Foiani

1 November 2003 in Cell
Verified
Journal Article
Closed access
GIGrzegorz Ira
Grzegorz Ira
AMAnna Malkova
Anna Malkova
GLGiordano Liberi
Giordano Liberi
MFMarco Foiani
Marco Foiani
JHJames Haber
James Haber

1 August 2002 in Molecular Cell
Verified
Journal Article
Closed access
MVMoreshwar B Vaze
Moreshwar B Vaze
APAchille Pellicioli
Achille Pellicioli
SLSang Eun Lee
Sang Eun Lee
GIGrzegorz Ira
Grzegorz Ira
GLGiordano Liberi
Giordano Liberi
JHJames Haber
James Haber

15 November 1999 in The EMBO Journal
Verified
Journal Article
Open access
PDF file
APAchille Pellicioli
Achille Pellicioli
CLChiara Lucca
Chiara Lucca
GLGiordano Liberi
Giordano Liberi
Federica MariniFederica Marini
Federica Marini
MLMassimo Lopes
Massimo Lopes
MFMarco Foiani
Marco Foiani
The Saccharomyces cerevisiae Rad53 protein kinase is required for the execution of checkpoint arrest at multiple stages of the cell cycle. We found that Rad53 autophosphorylation activity depends on in trans phosphorylation mediated by Mec1 and does not require physical association with other proteins. Uncoupling in trans phosphorylation from autophosphorylation using a rad53 kinase‐defective mutant results in a dominant‐negative checkpoint defect. Activation of Rad53 in response to DNA damage in G1 requires the Rad9, Mec3, Ddc1, Rad17 and Rad24 checkpoint factors, while this dependence is greatly reduced in S phase cells. Furthermore, during recovery from checkpoint activation, Rad53 activity decreases through a process that does not require protein synthesis. We also found that Rad53 modulates the lagging strand replication apparatus by controlling phosphorylation of the DNA polymerase α‐primase complex in response to intra‐S DNA damage.

1 November 2012 in Cell
Verified
Journal Article
Open access
AAAmaya Alzu
Amaya Alzu
Rodrigo BermejoRodrigo Bermejo
Rodrigo Bermejo
MBMartina Begnis
Martina Begnis
CLChiara Lucca
Chiara Lucca
DPDaniele Piccini
Daniele Piccini
GLGiordano Liberi
Giordano Liberi
Transcription hinders replication fork progression and stability. The ATR checkpoint and specialized DNA helicases assist DNA synthesis across transcription units to protect genome integrity. Combining genomic and genetic approaches together with the analysis of replication intermediates, we searched for factors coordinating replication with transcription. We show that the Sen1/Senataxin DNA/RNA helicase associates with forks, promoting their progression across RNA polymerase II (RNAPII)-transcribed genes. sen1 mutants accumulate aberrant DNA structures and DNA-RNA hybrids while forks clash head-on with RNAPII transcription units. These replication defects correlate with hyperrecombination and checkpoint activation in sen1 mutants. The Sen1 function at the forks is separable from its role in RNA processing. Our data, besides unmasking a key role for Senataxin in coordinating replication with transcription, provide a framework for understanding the pathological mechanisms caused by Senataxin deficiencies and leading to the severe neurodegenerative diseases ataxia with oculomotor apraxia type 2 and amyotrophic lateral sclerosis 4.